Raymond James Financial’s Milestone Pharmaceuticals MIST Stock Holding History
Bought
Maintained
Sold
Other funds holding MIST
KCM
Raymond James Financial's MIST Position: Q3 2026 in Review
Raymond James Financial reduced its Milestone Pharmaceuticals (MIST) stake by 12% in Q3 2026, selling an estimated $3.85K and leaving 26,600 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #5359.
Raymond James Financial first reported a position in MIST in Q1 2025 and has held it in 7 quarters since. The position peaked at $83.9K in Q2 2025. 74 funds tracked by Wall St. Rank hold MIST as of Q3 2026.
- Raymond James Financial held 26,600 shares of Milestone Pharmaceuticals worth $23K as of Q3 2026.
- Raymond James Financial sold 3,470 Milestone Pharmaceuticals shares in Q3 2026, an estimated $3.85K.
- Milestone Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #5359 holding.
- Raymond James Financial first reported a position in Milestone Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- Raymond James Financial's Milestone Pharmaceuticals position peaked at $83.9K in Q2 2025.
- 74 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.